Evaluation of Cetrotide pretreatment in patients with poor response to IVF Cycle.

Analysis of the result of pretreatment Antagonist GNRH in poor responder patients under treatment Antagonist GNRH in ICSI.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190602043792N1

Enrollment

Registered

2020-02-08

Start date

2019-08-11

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility. Female infertility

Interventions

Intervention 1: Intervention group:The patients reciept cetrotide for three days that started from day 2 and after that HMG and FSH is started and then when the follicle is upper 13-millimeter cetroti

Eligibility

Sex/Gender

Female

Age

25 Years to 40 Years

Inclusion criteria

Inclusion criteria: The age lower than 40 year old Antral folicle lower than 5 mili metr in each ovary AMH lower than 2/1 History of low response in previous cycle

Exclusion criteria

Exclusion criteria: The age higher than 40 Oncofertility

Design outcomes

Primary

Measure	Time frame
Retrieved oocytes. Timepoint: On day of the ovarian follicle puncture. Method of measurement: observation with microscope by embriologist.	—

Secondary

Measure	Time frame
The number of oocyte metaphas 2. Timepoint: On oocyte retrieval day. Method of measurement: Observation oocyte with microscope by embrologist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Farajzadeh Vajari

Tehran University of Medical Sciences

fatemeh_582003@yahoo.com+98 21 6693 9320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026